eISSN: 2449-8238
ISSN: 2392-1099
Clinical and Experimental Hepatology
Current issue Archive Manuscripts accepted About the journal Editorial board Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
IMPACT FACTOR
2023
1.5
MNiSW
20*
Indexed in:
ESCI

Web of Science
Clarivate Analytics
JCI
0.31

Journal Citation Indicator
CiteScore 2023
2.8
 
NEW Guidelines for Authors!

The current MNiSW score is temporary and results from the decision of the Minister of Science and Higher Education to withdraw scores from all journals that received an increase in score in 2023. The decision is the result of the need to develop a new scoring system. However, all articles published in 2023 are awarded 200 MNiSW points, and the actual score for 2024 will be determined at the end of the year.

Obecna punktacja MEiN ma charakter tymczasowy i wynika z decyzji Ministra Nauki i Szkolnictwa Wyższego o wycofaniu punktacji wszystkim czasopismom, które w 2023 r. uzyskały podwyższenie punktacji. Decyzja ta wynika z konieczności opracowania nowego systemu punktacji. Natomiast wszystkie artykuły opublikowane w roku 2023 otrzymują 200 punktów MNiSW, a ostateczna punktacja za rok 2024 zostanie ustalona na koniec roku.


Clinical and Experimental Hepatology, is the official journal of the Polish Association for Study of Liver.

Indexed in PubMed and Web of Science Core Collection
4/2023
vol. 9
 
 

 
Review paper

Porto-sinusoidal vascular disease: a new definition of an old clinical entity

Mislav Barisic-Jaman, Marko Milosevic, Frane Pastrovic, Anita Skrtic, Ivica Grgurevic
Clin Exp HEPATOL 2023; 9, 4: 297-306
Online publish date: 2023-11-24
 
DOI : https://doi.org/10.5114/ceh.2023.133107
Review paper

The role of microRNAs in hepatocellular carcinoma: Therapeutic targeting of tumor suppressor and oncogenic genes

Nasim Rahimi Farsi, Bahman Naghipour, Parviz Shahabi, Reza Safaralizadeh, Khalil Hajiasgharzadeh, Narges Dastmalchi, Mohammad Reza Alipour
Clin Exp HEPATOL 2023; 9, 4: 307-319
Online publish date: 2023-09-28
 
DOI : https://doi.org/10.5114/ceh.2023.131669
Original paper

Real-world effectiveness of genotype-specific and pangenotypic direct-acting antivirals in HCV-infected patients with renal failure

Olga Tronina, Michał Brzdęk, Dorota Zarębska-Michaluk, Beata Lorenc, Justyna Janocha-Litwin, Hanna Berak, Marek Sitko, Dorota Dybowska, Włodzimierz Mazur, Magdalena Tudrujek-Zdunek, Ewa Janczewska, Jakub Klapaczyński, Witold Dobracki, Anna Parfieniuk-Kowerda, Rafał Krygier, Łukasz Socha, Robert Flisiak
Clin Exp HEPATOL 2023; 9, 4: 320-334
Online publish date: 2023-12-15
 
DOI : https://doi.org/10.5114/ceh.2023.133307
Original paper

Does amyloid b precursor protein gene expression have a role in diagnosis of biliary atresia?

Salma Abdel Megeed Nagi, Heba Mohamed Abdallah, Abeer Abdelfattah El Gazzar, Bassam Abdel Hakam Ayoub, Mohammed Abdel-Hafez Ali, Marwa Sabry
Clin Exp HEPATOL 2023; 9, 4: 335-343
Online publish date: 2023-11-14
 
DOI : https://doi.org/10.5114/ceh.2023.132818
Original paper

Concomitant diverticulosis among patients undergoing liver transplantation. Does it influence the length of hospitalization after the procedure?

Tomasz Menżyk, Lubomir Skladany, Svetlana Adamcova-Selcanova, Janka Vnencakova, Daniela Zilincanova, Natalia Bystrianska, Dorota Hudy, Magdalena Skonieczna, Wojciech Marlicz, Michał Kukla
Clin Exp HEPATOL 2023; 9, 4: 344-350
Online publish date: 2023-11-13
 
DOI : https://doi.org/10.5114/ceh.2023.132255
Original paper

Comparison of intravenous terlipressin infusion versus bolus in patients with acute-on-chronic liver failure–acute kidney injury – an open label RCT

Tarana Gupta, Ashank Goel, Naveen Ranga, Sandeep K. Goyal
Clin Exp HEPATOL 2023; 9, 4: 351-358
Online publish date: 2023-12-05
 
DOI : https://doi.org/10.5114/ceh.2023.132813
Original paper

Methotrexate-induced hepatotoxicity in rats and the therapeutic properties of vitamin E: a histopathologic and flowcytometric research

Ahmet U. Akman, Zuleyha Erisgin, Sibel Turedi, Yavuz Tekelioglu
Clin Exp HEPATOL 2023; 9, 4: 359-367
Online publish date: 2023-10-27
 
DOI : https://doi.org/10.5114/ceh.2023.132251
Original paper

Thrombospondin-2 as a potential noninvasive biomarker of hepatocyte injury but not liver fibrosis in children with MAFLD: A preliminary study

Katarzyna Zdanowicz, Marta Flisiak-Jackiewicz, Anna Bobrus-Chociej, Monika Kowalczuk-Kryston, Jacek Jamiolkowski, Diana Martonik, Magdalena Rogalska, Dariusz M. Lebensztejn
Clin Exp HEPATOL 2023; 9, 4: 368-374
Online publish date: 2023-11-22
 
DOI : https://doi.org/10.5114/ceh.2023.133108
Original paper

The influence of steroid therapy of complications of infectious mononucleosis on the course of Epstein-Barr virus hepatitis

Magdalena Rutkowska, Maria Pokorska-Śpiewak
Clin Exp HEPATOL 2023; 9, 4: 375-385
Online publish date: 2023-11-24
 
DOI : https://doi.org/10.5114/ceh.2023.133169
Original paper

N-acetylcysteine acts as a potent anti-inflammatory agent altering the eicosanoid profile in the development of simple steatosis and its progression to hepatitis

Klaudia Sztolsztener, Janusz Dzięcioł, Adrian Chabowski
Clin Exp HEPATOL 2023; 9, 4: 386-395
Online publish date: 2023-12-05
 
DOI : https://doi.org/10.5114/ceh.2023.133106
Short report

Increased aminotransferases do not necessarily mean hepatotoxicity of CFTR modulator therapy

Marek Woynarowski, Ewa Sapiejka, Maria Jóźwiak, Aldona Wierzbicka-Rucińska
Clin Exp HEPATOL 2023; 9, 4: 405-409
Online publish date: 2023-11-28
 
DOI : https://doi.org/10.5114/ceh.2023.132264
Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.